[1] |
Römling U, Galperin MY, Gomelsky M . Cyclic di-GMP: the first 25 years of a universal bacterial second messenger. Microbiol Mol Biol Rev, 2013,77(1):1-52.
doi: 10.1128/MMBR.00043-12
URL
pmid: 23471616
|
[2] |
Pesavento C, Hengge R . Bacterial nucleotide-based second messengers. Curr Opin Microbiol, 2009,12(2):170-176.
doi: 10.1016/j.mib.2009.01.007
URL
pmid: 19318291
|
[3] |
Bobrov AG, Kirillina O, Ryjenkov DA , et al. Systematic analy-sis of cyclic di-GMP signalling enzymes and their role in biofilm formation and virulence in Yersinia pestis. Mol Microbiol, 2011,79(2):533-551.
doi: 10.1111/mmi.2011.79.issue-2
URL
|
[4] |
Hu DL, Narita K, Hyodo M , et al. c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resis-tant Staphylococcus aureus (MRSA) infection. Vaccine, 2009,27(35):4867-4873.
doi: 10.1016/j.vaccine.2009.04.053
URL
|
[5] |
Zhang HN, Xu ZW, Jiang HW , et al. Cyclic di-GMP regulates Mycobacterium tuberculosis resistance to ethionamide. Sci Rep, 2017,7(1):5860.
doi: 10.1038/s41598-017-06289-7
URL
pmid: 5517500
|
[6] |
Hong Y, Zhou X, Fang H , et al. Cyclic di-GMP mediates Mycobacterium tuberculosis dormancy and pathogenecity. Tuberculosis (Edinb), 2013,93(6):625-634.
doi: 10.1016/j.tube.2013.09.002
URL
pmid: 24080120
|
[7] |
王琳 . 结核分枝杆菌c-di-GMP代谢相关蛋白的生物化学研究. 安徽: 中国科学技术大学, 2010.
doi: 10.7666/d.y1705644
URL
|
[8] |
Parish T, Stoker NG. Mycobacterium tuberculosis protocols. Clifton: Humana Press, 2001.
|
[9] |
Kulka K, Hatfull G, Ojha AK . Growth of Mycobacterium tuberculosis biofilms. J Vis Exp, 2012, (60). pii: 3820.
|
[10] |
Kumar A, Toledo JC, Patel RP , et al. Mycobacterium tuberculosis DosS is a redox sensor and DosT is a hypoxia sensor. Proc Natl Acad Sci U S A, 2007,104(28):11568-11573.
doi: 10.1073/pnas.0705054104
URL
|
[11] |
Peddireddy V, Doddam SN, Ahmed N . Mycobacterial dormancy systems and host responses in tuberculosis. Front Immunol, 2017,8:84.
doi: 10.3389/fimmu.2017.00084
URL
pmid: 28261197
|
[12] |
Ojha AK, Baughn AD, Sambandan D , et al. Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug-tolerant bacteria. Mol Microbiol, 2008,69(1):164-174.
doi: 10.1111/mmi.2008.69.issue-1
URL
|
[13] |
Hall-Stoodley L, Costerton JW, Stoodley P . Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol, 2004,2(2):95-108.
doi: 10.1038/nrmicro821
URL
pmid: 15040259
|
[14] |
Donlan RM . Biofilms on central venous catheters: is eradication possible? Curr Top Microbiol Immunol, 2008,322:133-161.
doi: 10.1007/978-3-540-75418-3_7
URL
pmid: 18453275
|
[15] |
Hatt JK, Rather PN . Role of bacterial biofilms in urinary tract infections. Curr Top Microbiol Immunol, 2008,322:163-192.
|
[16] |
Martínez LC, Vadyvaloo V . Mechanisms of post-transcriptional gene regulation in bacterial biofilms. Front Cell Infect Microbiol, 2014,4:38.
doi: 10.3389/fcimb.2014.00038
URL
pmid: 24724055
|
[17] |
Leistikow RL, Morton RA, Bartek IL , et al. The Mycobacterium tuberculosis DosR regulon assists in metabolic homeostasis and enables rapid recovery from nonrespiring dormancy. J Bacteriol, 2010,192(6):1662-1670.
doi: 10.1128/JB.00926-09
URL
|
[18] |
Dokladda K, Billamas P, Palittapongarnpim P . Different behaviours of promoters in Mycobacterium tuberculosis H37Rv and H37Ra. World J Microbiol Biotechnol, 2015,31(2):407-413.
doi: 10.1007/s11274-014-1794-x
URL
pmid: 25556328
|